SINOPHARM GROUP 1/5/O.N. (X2S1) — Tangible Net Worth Ratio
SINOPHARM GROUP 1/5/O.N. (X2S1) has a Tangible Net Worth Ratio of 96.7% as of December 2025. This metric is calculated by deducting intangible assets (€4.36 Billion) from net assets (€134.16 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of SINOPHARM GROUP 1/5/O.N. to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
SINOPHARM GROUP 1/5/O.N. Tangible Net Worth Ratio (2021–2025)
This chart shows how SINOPHARM GROUP 1/5/O.N.'s Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 96.7%, reflecting net assets of €134.16 Billion with intangible assets of €4.36 Billion EUR. For live market cap and overall valuation, see market value of SINOPHARM GROUP 1/5/O.N..
Annual Tangible Net Worth Ratio for SINOPHARM GROUP 1/5/O.N. (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for SINOPHARM GROUP 1/5/O.N. from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore SINOPHARM GROUP 1/5/O.N. (X2S1) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.7% | €134.16 Billion | €4.36 Billion | €390.36 Billion | ▲ +0.5 pp |
| 2024 | 96.3% | €126.69 Billion | €4.72 Billion | €392.83 Billion | ▲ +0.3 pp |
| 2023 | 96.0% | €120.32 Billion | €4.86 Billion | €383.39 Billion | ▲ +0.4 pp |
| 2022 | 95.6% | €110.07 Billion | €4.87 Billion | €364.78 Billion | ▲ +0.6 pp |
| 2021 | 95.0% | €99.65 Billion | €5.00 Billion | €335.41 Billion | — |